- US-listed companies
- Nutex Health Inc.
- Income statement
Nutex Health Inc. (NUTX) Income statement
Market cap
$704.15M
P/E ratio
9.6x
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | - | - | - | - | - | - | 23,166 | 1 | 2 | 19 | 219 | 248 | 480 | 875 |
| Revenue growth (%) | - | - | - | - | - | - | - | - | ||||||
| Cost of revenue | - | - | - | - | - | - | 30,481 | 830,443 | 909,780 | 15 | - | - | - | - |
| Gross profit | - | - | - | - | - | - | -7,315 | 535,976 | 676,172 | 4 | 13 | 35 | 196 | 444 |
| Gross margin (%) | - | - | - | - | - | - | ||||||||
| Research & development | - | - | - | - | - | - | - | 768,103 | 557,257 | 285,880 | - | - | - | - |
| Operating margin (%) | - | - | - | - | - | - | ||||||||
| Operating expenses | - | - | - | - | - | - | 6 | 7 | 6 | 13 | 420 | 213 | 284 | 431 |
| Operating income | - | - | - | - | - | - | -5,692,920 | -6,897,848 | -5,187,702 | -9,018,075 | -406,599,154 | -31,773,748 | 131 | 276 |
| Income before tax | - | - | - | - | - | - | - | - | -5,689,919 | -14,653,434 | -419,648,713 | -48,490,799 | 110 | 245 |
| Pretax margin (%) | - | - | - | - | - | - | - | - | -358.8 | -78 | -191.4 | -19.6 | 22.9 | 28 |
| Provision for income taxes | - | - | - | - | - | - | - | - | - | -984,810 | 13 | -5,067,084 | 14 | 64 |
| Effective tax rate (%) | - | - | - | - | - | - | - | - | - | |||||
| Net income | -383,393 | -1,623,895 | 250,489 | -684,342 | 83,809 | -7,432,241 | 582,062 | -7,116,520 | -5,650,167 | -13,668,624 | -424,780,446 | -43,423,715 | 95 | 180 |
| Net income margin (%) | - | - | - | - | - | - | ||||||||
| Earnings per share | - | - | - | - | - | - | - | - | - | - | -0.67 | -0.07 | 10.25 | 11.13 |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | -0.67 | -0.07 | 9.71 | 10.48 |
| EBITDA | - | - | - | - | - | - | - | - | - | |||||
| EBITDA margin (%) | - | - | - | - | - | - | - | - | - |